TriSalus Life Sciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $24.6M
Liabilities Breakdown FY2023
Total Liabilities: $51.7M
Asset Breakdown
Total Assets: $24.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $11.8M | 47.9% |
| Accounts Receivable | $3.6M | 14.4% |
| Inventory | $2.5M | 10.3% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $6.7M | 27.3% |
Liabilities Breakdown
Total Liabilities: $51.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.4M | 6.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $48.3M | 93.4% |